Company intelligence / Profile preview

Vetoquinol

Lure, Haute-Saône, Francevetoquinolusa.com ↗
Ownership
Public · VETO
Employees
~2519
Development stage
Commercial
01

Overview

Vetoquinol has a broad commercial portfolio of veterinary medicines and non-medicinal products targeting pain/inflammation, dermatology, hygiene/care, udder health, reproduction, cardio-nephrology, behavior management. Recent regulatory milestones include FDA approvals for Clevor (emetic agent) and UpCard CA1 (for canine pulmonary edema). The company continues to launch new products such as VetPowerment.[5]

Therapeutic areas
OtherPsychiatryDermatologyRheumatologyCardiovascular
Modalities
Small molecules (veterinary drugs and supplements)[5]Diagnostics[5]Digital applications/services[5]
Industry
Veterinary
02

Drug pipeline

2 assets

Drontal

Commercial
Indications
Animal parasites

1 more asset in the full pipeline.

Request access →
03

Partnerships

Not specifically listed; the company collaborates with distributors worldwide but no major pharma co-development partnerships disclosed.
04

Financials

Market cap
$356.5M
Total revenue
$32.3M

Beyond the preview

Go deeper on Vetoquinol.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vetoquinol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call